UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

close
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

close
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI POCT14

Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline

inactive
Buy Now
Organization: CLSI
Publication Date: 1 July 2004
Status: inactive
Page Count: 48
scope:

This document deals only with the use of POC-CT in monitoring of anticoagulant therapy with unfractionated heparin (hereafter called "heparin") and warfarin. It does not address issues related to the use of POC-CT in the evaluation of patients with suspected hemostatic disorders or use of other anticoagulants. There are many potential sites for POC-CT, such as hospitals, physicians' offices, and patients' homes. Those performing POC-CT may include healthcare professionals and patient caregivers, as well as patients.

Document History

July 1, 2020
Point-of-Care Coagulation Testing and Anticoagulation Monitoring
This guideline provides recommendations for establishing and/or assessing performance characteristics of traditional assays for coagulation assessment and anticoagulation management that are...
CLSI POCT14
July 1, 2004
Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline
This document deals only with the use of POC-CT in monitoring of anticoagulant therapy with unfractionated heparin (hereafter called "heparin") and warfarin. It does not address issues related to the...

References

Advertisement